Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zhejiang Chemsyn Pharm CoBJSE:920656 43 PB Ratio is 1.96 as of Aug. 12, 2026, which is 20% below its 10-year median of 2.45. GuruFocus rates BJSE:920656 with a GF Score™ of 43/100. The stock has 4 warning signs investors should review. Among 18 Healthcare Plans companies, Zhejiang Chemsyn Pharm Co ranks better than 55.56% on this metric.
Zhejiang Chemsyn Pharm Co Ltd stock PB Ratio (=1.97) is close to 1-year low of 1.8.
The historical rank and industry rank for Zhejiang Chemsyn Pharm Co's PB Ratio or its related term are showing as below:
BJSE:920656'
s PB Ratio Range Over the Past 10 Years
Min: 1.51 Med: 2.45 Max: 5.6
Current: 1.96
During the past 12 years, Zhejiang Chemsyn Pharm Co's highest PB Ratio was 5.60. The lowest was 1.51. And the median was 2.45.
BJSE:920656's PB Ratio is ranked better than 55.56% of 18
companies
in the Healthcare Plans industry
Industry Median: 2.38
vs BJSE:920656: 1.96
During the past 12 months, Zhejiang Chemsyn Pharm Co's average Book Value Per Share Growth Rate was 8.60% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 39.70% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 37.50% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 38.20% per year.
During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of Zhejiang Chemsyn Pharm Co was 48.80% per year. The lowest was 21.30% per year. And the median was 42.40% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Zhejiang Chemsyn Pharm Co PB Ratio Related Terms
Zhejiang Chemsyn Pharm Co PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Healthcare Plans subindustry, Zhejiang Chemsyn Pharm Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Chemsyn Pharm Co PB Ratio vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Zhejiang Chemsyn Pharm Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Zhejiang Chemsyn Pharm Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Zhejiang Chemsyn Pharm Co (BJSE:920656) has a PB Ratio of 1.96 as of Aug. 12, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Zhejiang Chemsyn Pharm Co and its competitors. This is 20% below median its historical median of 2.45. Over the past decade, Zhejiang Chemsyn Pharm Co's PB Ratio has ranged from 1.51 to 5.60. According to the industry distribution chart, Zhejiang Chemsyn Pharm Co ranks #8 out of 18 companies in the Healthcare Plans industry, placing it in the top 44.4%.
Is Zhejiang Chemsyn Pharm Co's PB Ratio too high?
Zhejiang Chemsyn Pharm Co's current PB Ratio of 1.96 is 20% below median its 10-year median of 2.45. Over the past 10 years, this metric has ranged from a low of 1.51 to a high of 5.60. The Healthcare Plans industry median PB Ratio is 2.38. Zhejiang Chemsyn Pharm Co's value of 1.96 is 17.6% below this industry median. Based on the distribution chart, Zhejiang Chemsyn Pharm Co ranks #8 out of 18 companies in the Healthcare Plans industry, which is above the industry midpoint. Overall, Zhejiang Chemsyn Pharm Co has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Chemsyn Pharm Co's PB Ratio compare to UNH and CVS?
According to the Healthcare Plans industry distribution chart, Zhejiang Chemsyn Pharm Co ranks #8 out of 18 companies for PB Ratio. This puts Zhejiang Chemsyn Pharm Co in the upper half of its industry. The industry median PB Ratio is 2.38. Zhejiang Chemsyn Pharm Co's value of 1.96 is 17.6% below this benchmark. Historically, Zhejiang Chemsyn Pharm Co's own PB Ratio has ranged from 1.51 to 5.60 over the past decade. While the company's 10-year median is 2.45 vs. the industry median of 2.38, Zhejiang Chemsyn Pharm Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Plans company?
The median PB Ratio among Healthcare Plans companies is 2.38, based on 18 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhejiang Chemsyn Pharm Co's current PB Ratio of 1.96 is 17.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Zhejiang Chemsyn Pharm Co and its competitors. For the Healthcare Plans industry, the median PB Ratio is 2.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Chemsyn Pharm Co's current PB Ratio is 1.96, which is 20% below median its own 10-year median of 2.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Chemsyn Pharm Co stock overvalued right now?
Zhejiang Chemsyn Pharm Co (BJSE:920656) has a current PB Ratio of 1.96. The current PB Ratio is 1.96, which is 20% below median its 10-year median of 2.45 and 17.6% below the Healthcare Plans industry median of 2.38. Zhejiang Chemsyn Pharm Co's overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Zhejiang Chemsyn Pharm Co (BJSE:920656), the current PB Ratio is 1.96 as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Zhejiang Chemsyn Pharm Co Ltd is engaged in Research, development, production and sales of veterinary drug raw materials, pharmaceutical raw materials and intermediates.
43GF Score
Get the complete analysis for BJSE:920656
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920656 has been successfully added to your 
